Dag Hjelle • 1959 • Oslo • 12 roles • 7 shareholdings

This website uses cookies to enhance the user experience.

Roles

Management

Name	Role	Total operating income	Total equity	Shares
M MEDCIS AS	Managing Director/CEO	402,730	221,964	100 % directly
F FJORD MEDICAL AS	Managing Director/CEO	-	173,748	100 % indirectly
F FOLVENGAARD AQUA AS	Managing Director/CEO	-	583,537	48 % indirectly
P PURECUT TECHNOLOGIES AS	Managing Director/CEO	-	1,092,693	33.33 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
M MEDCIS AS	Chairman	402,730	221,964	100 % directly
F FJORD MEDICAL AS	Chairman	-	173,748	100 % indirectly
F FOLVENGAARD AS	Chairman	3,792,389	354,299	60 % directly
F FOLVENGAARD AQUA AS	Board Member	-	583,537	48 % indirectly
P PURECUT TECHNOLOGIES AS	Chairman	-	1,092,693	33.33 % indirectly
B BIOSYNTECH AS	Board Member	-	37,228	20 % indirectly
H HJELLEDALEN KRAFTLAG AS	Board Member	2,015,799	3,322,297	9.52 % directly
D DAG HJELLE	Holder	-	-	-

Last update: Jun 27, 2025

Related industries5

Direct relationships5

RO
Rolf Olav Reitan Gjørven1991
HJELLEDALEN KRAFTLAG AS, FOLVENGAARD AS
ØS
Øystein Selen1961
BIOSYNTECH AS
SJ
Stig Jarle Rødseth1955
FOLVENGAARD AQUA AS
TK
Tom Kristian Hoffmann1948
BIOSYNTECH AS
EF
Eli Folven1983
HJELLEDALEN KRAFTLAG AS

Shares owned by Dag Hjelle

Name	Share class	Total operating income	Total equity	Share
M MEDCIS AS	Ordinære aksjer	402,730	221,964	100 % directly
F FJORD MEDICAL AS		0	173,748	100 % indirectly
F FOLVENGAARD AS	Ordinære aksjer	3,792,389	354,299	60 % directly
F FOLVENGAARD AQUA AS		0	583,537	48 % indirectly
P PURECUT TECHNOLOGIES AS		0	1,092,693	33.33 % indirectly
B BIOSYNTECH AS		0	37,228	20 % indirectly
H HJELLEDALEN KRAFTLAG AS	Ordinære aksjer	2,015,799	3,322,297	9.52 % directly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025